Scripx Pharmacy & Health

Scripx Pharmacy & Health

Growth Stage

Evolving the access and affordability of medications via tech and automation

Evolving the access and affordability of medications via tech and automation

Overview

Raised to Date: Raised: $45,951

Total Commitments ($USD)

Platform

Republic

Start Date

08/23/2022

Close Date

01/31/2023

Min. Goal
$25,000
Max. Goal
$1,070,000
Min. Investment

$100

Security Type

SAFE

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$12,000,000

Discount

0%

Rolling Commitments ($USD)

Status
Funded
Reporting Date

02/04/2023

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$287

# of Investors

107

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2021

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2C

Margin

Low

Capital Intensity

Low

Location

Plano, Texas

Business Type

Growth

Scripx Pharmacy & Health, with a valuation of $12 million, is raising funds on Republic. It is an on-demand delivery pharmacy service. The business is customer-centric and uses advanced technology to deliver, manage, and administer pharmacy services. The users can transfer their refills or new prescriptions to Scripx and get them delivered at their convenience. Scripx Pharmacy & Health reported a 300% increase in prescriptions delivered since the end of 2020 and a 250% revenue growth from 2020 to 2021. Jon Eaton founded Scripx Pharmacy & Health in March 2021. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1,070,000. The campaign proceeds will be used for expansion to new locations, marketing, and new partnerships.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$1,910,831

$557,891

COGS

$1,928,213

$453,488

Tax

$0

$0

 

 

Net Income

$-372,099

$-126,692

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$63,513

$6,579

Accounts Receivable

$119,000

$85,476

Total Assets

$940,877

$218,821

Short-Term Debt

$333,389

$131,483

Long-Term Debt

$761,455

$7,872

Total Liabilities

$1,094,844

$139,355

Financials as of: 08/23/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars

Analyst Report Analyst Report Methodology Article

Scripx is following in the footsteps of NowRx and Capsule. It’s a Dallas-based virtual pharmacy operating within the Dallas-Fort Worth metropolitan area. Scripx offers prescription fulfillment and delivery as well as limited telehealth services. Customers can use the company’s mobile app to upload insurance documents, track their prescriptions, and order refills. But there are a few things investors should consider before investing in a duplicative company like Scripx. Rather than blazing a new trail, it’s following the drug delivery service playbook created by NowRX and Capsule. And that comes with its own mix of advantages and disadvantages.

Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
Scripx Pharmacy & Health on Republic 2022
Platform: Republic
Security Type: SAFE
Valuation: $12,000,000

Follow company

Follow Scripx Pharmacy & Health on Republic 2022

Buy Scripx Pharmacy & Health's Deal Report

Warning: according to the close date for this deal, Scripx Pharmacy & Health may no longer be accepting investments.

Scripx Pharmacy & Health Deal Report

Get KingsCrowd’s comprehensive report on Scripx Pharmacy & Health including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Scripx Pharmacy & Health is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise
  • Our deep-dive analyst report reviewing the deal's investment potential and bullish vs. bearish outlook

Buy the Scripx Pharmacy & Health deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge